TSLC1 gene silencing in cutaneous melanoma

Melanoma Research

Volumn 20, Issue 3, 2010, Pages 179-183

  You, Yan ^a   Ma, Liangjuan ^c   You, Min ^c   Li, Xiaomei ^a   Wang, Shuhai ^a   Li, Hongli ^a   Wu, Debin ^d   Yang, Huimin ^e   Li, Zhen Yu ^b  

^a Third Affiliated Hospital   (China)

^b HARBIN MEDICAL UNIVERSITY   (China)

^c Provincial Hospital   (China)

^d Seventh Hospital   (China)

^e Provincial Second Hospital   (China)

Author keywords

Cutaneous melanoma; Methylation; Tumor suppressor in lung cancer 1

Indexed keywords

GENOMIC DNA; TUMOR SUPPRESSOR IN LUNG CANCER 1; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; CADM1 PROTEIN, HUMAN; CELL ADHESION MOLECULE; IMMUNOGLOBULIN;

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CANCER TISSUE; CARCINOGENESIS; CONTROLLED STUDY; EPIGENETICS; FEMALE; GENE INACTIVATION; GENE SILENCING; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MELANOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN METHYLATION; DNA METHYLATION; GENE EXPRESSION PROFILING; GENETIC EPIGENESIS; GENETICS; PROCEDURES; SKIN TUMOR; TREATMENT OUTCOME; TUMOR CELL LINE;

CELL ADHESION MOLECULES; CELL LINE, TUMOR; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; GENE EXPRESSION PROFILING; GENE SILENCING; HUMANS; IMMUNOGLOBULINS; IMMUNOHISTOCHEMISTRY; MALE; MELANOMA; PROGNOSIS; PROMOTER REGIONS, GENETIC; SKIN NEOPLASMS; TREATMENT OUTCOME; TUMOR SUPPRESSOR PROTEINS;

EID: 77952241925     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/CMR.0b013e32833413c0     Document Type: Article

References (15)

1. Marks R. Epidemiology of melanoma. Clin Exp Dermatol 2000;25:459-463.
2. Masuda M, Yageta M, Fukuhara H, Kuramochi M, Maruyama T, Nomoto A, et al. The tumor suppressor protein TSLC1 is involved in cell-cell adhesion. J Biol Chem 2002;277:31014-31019.
3. Kuramochi M, Fukuhara H, Nobukuni T, Kanbe T, Maruyama T, Ghosh HP. TSLC1 is a tumor-suppressor gene in human non-small-cell lung cancer. Nat Genet 2001;27:427-430.
4. Tamura G. Promoter methylation status of tumor suppressor and tumorrelated genes in neoplastic and non-neoplastic gastric epithelia. Histol Histopathol 2004;19:221-228.
5. Honda T, Tamura G, Waki T, Jin Z, Sato K, Motoyama T, et al. Hypermethylation of the TSLC1 gene promoter in primary gastric cancers and gastric cancer cell lines. Jpn J Cancer Res 2002;3:857-860.
6. Jansen M, Fukushima N, Rosty C, Walter K, Altink R, Heek TV, et al. Aberrant methylation of the 5-CpG island of TSLC1 is common in pancreatic ductal adenocarcinoma and is first manifest in high-grade PanlNs. Cancer Biol Ther 2002;1:293-296.
7. Allinen M, Peri L, Kujala S, Lahti-Domenici J, Outila K, Karppinen SM, et al. Analysis of 11q21-24 loss of heterozygosity candidate target genes in breast cancer: indications of TSLC1 promoter hypermethylation. Genes Chromosomes Cancer 2002;34:384-389.
8. Hui AB, lo KW, Kwong J, Lam EC, Chan SY, Chow LS, et al. Epigenetic inactivation of TSLC1 gene in nasopharyngeal carcinoma. Mol Carcinog 2003;38:170-178.
9. Fukuhara H, Kuramochi M, Fukami T, Kasahara K, Furuhata M, Nobukuni T, et al. Promoter methylation of TSLC1 and tumor suppression by its gene product in human prostate cancer. Jpn J Cancer Res 2002;93:605-609.
10. Steenbergen RD, Kramer D, Braakhuis BJ, Stern PL, Verheijen RH, Meijer CJ, et al. TSLC1 gene silencing in cervical cancer cell lines and cervical neoplasia. J Natl Cancer Inst 2004;96:294-305.
11. Yageta M, Kuramochi M, Masuda M, Fukami T, Fukuhara H, Maruyama T, et al. Direct association of TSLC1 and DAL-1, two distinct tumor suppressor proteins in lung cancer. Cancer Res 2002;62:5129-5133.
12. Fukami T, Fukuhara H, Kuramochi M, Maruyama T, Isogai K, Sakamoto M, et al. Promoter methylation of the TSLC1 gene in advanced lung tumors and various cancer cell lines. Int J Cancer 2003;107:53-59.
13. Murakami Y. Functional cloning of a tumor suppressor gene, TSLC1, in human non-small cell lung cancer. Oncogene 2002;21:6936-6948.
14. Ito T, Shimoto Y, Kaganoi J, Kan T, Wantanabe G. Involvement of TSLC1 in progression of esophageal squamous cell carcinoma. Cancer Res 2003;63:6320-6326.
15. Uchino K, Ito A, Wakayama T, Koma Y, Okada T, Ohbayashi C, et al. Clinical implication and prognostic significance of the tumor suppressor TSLC1 gene detected in adenocarcinoma of the lung. Cancer 2003;98:1002-1007.